United States · Venture startup

Who invested in Confluence Pharmaceuticals

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$200Kraised across 1 round since 2022, from 1 source

Latest round
Venture, $200KJun 2022
Investors
1
See who backed them

The rounds

  1. Jun 2022
    Venture$200K

    Source recorded

Everyone who backed them

Elevate VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Confluence Pharmaceuticals as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Elevate VenturesAngel networkPer its own site
IU VenturesAngel networkPer its own site

Quick answers about Confluence Pharmaceuticals

Who invested in Confluence Pharmaceuticals?

Confluence Pharmaceuticals's investors include Elevate Ventures.

How much has Confluence Pharmaceuticals raised?

Confluence Pharmaceuticals has raised $200K across 1 round since 2022.

When did Confluence Pharmaceuticals last raise?

Confluence Pharmaceuticals's most recent round was a Venture of $200K in Jun 2022.

What was Confluence Pharmaceuticals's biggest round?

Its most recent round, $200K in Jun 2022, is also its largest on record.

Who backed Confluence Pharmaceuticals first?

Confluence Pharmaceuticals's first round on record, in Jun 2022, was backed by Elevate Ventures.

What stage is Confluence Pharmaceuticals at?

Confluence Pharmaceuticals's latest named round is a Venture, in Jun 2022.

Where is Confluence Pharmaceuticals based?

Confluence Pharmaceuticals is based in the United States.

Companies like Confluence Pharmaceuticals

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.